PMID- 23278608 OWN - NLM STAT- MEDLINE DCOM- 20130620 LR - 20211203 IS - 1365-4632 (Electronic) IS - 0011-9059 (Linking) VI - 52 IP - 1 DP - 2013 Jan TI - Human leukocyte antigens class I and class II in patients with pemphigus in southern Turkey. PG - 53-8 LID - 10.1111/j.1365-4632.2012.05541.x [doi] AB - BACKGROUND: Genetic factors that predispose individuals to pemphigus are considered to play important roles in the development of the disease. Furthermore, population studies of patients with pemphigus have clearly shown that the most prevalent alleles differ across ethnic groups. OBJECTIVES: This controlled study was designed to detect the distribution of human leukocyte antigen (HLA) class I and II alleles in Turkish patients with pemphigus. METHODS: Sixty patients diagnosed with pemphigus according to clinical findings, histology, immunofluorescence, and enzyme-linked immunosorbent assay (ELISA) were enrolled in the study. The control group consisted of 60 healthy adult transplant donors. HLA typing was carried out using a polymerase chain reaction (PCR) with sequence-specific primers (SSP) method. RESULTS: The frequencies of HLAs A*11, CW*01, DRB1*04, DRB1*14, DQB1*05, and DPB1*0401 were found to be statistically significantly higher in the disease group than in controls. By contrast, the frequencies of HLAs B*18, B*50, DRB1*11, DQB1*02, DQB1*06, DPB1*0301, and DPB1*1102 were statistically significantly lower in the pemphigus group than in controls. Linkage dysequilibrium analysis showed that DRB1*14/DQB1*05, A*11/DQB1*05, and A*11/DRB1*14 alleles were detected frequently in pemphigus patients, and DRB1*11/DQB1*05, DRB1*14/DQB1*02, B*50/DQB1*02, and B*50/DPB1*0301 alleles appeared frequently in healthy controls. CONCLUSIONS: The results suggest that DRB1*04, DRB1*14, DQB1*05, and DPB1*0401 class II HLAs and A*11 and CW*01 class I HLAs are associated with pemphigus in southern Turkey. Observed differences in LD patterns between patients and controls suggest that the coexistence of the respective alleles is strongly determinant of predisposition towards (DRB1*14/DQB1*05 and A*11/DQB1*05) or protection against (B*50/DQB1*02) the disease. CI - (c) 2013 The International Society of Dermatology. FAU - Koc, Cilem Kaya AU - Koc CK AD - Department of Dermatology and Venereology, Akdeniz University School of Medicine, Antalya, Turkey. FAU - Sallakci, Nilgun AU - Sallakci N FAU - Akman-Karakas, Ayse AU - Akman-Karakas A FAU - Alpsoy, Erkan AU - Alpsoy E FAU - Yegin, Olcay AU - Yegin O LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - England TA - Int J Dermatol JT - International journal of dermatology JID - 0243704 RN - 0 (HLA Antigens) RN - 0 (Histocompatibility Antigens Class I) RN - 0 (Histocompatibility Antigens Class II) SB - IM MH - Adult MH - Aged MH - Alleles MH - Case-Control Studies MH - Enzyme-Linked Immunosorbent Assay MH - Ethnicity/genetics MH - Female MH - Gene Frequency MH - Genetic Predisposition to Disease MH - HLA Antigens/*genetics MH - Haplotypes MH - Histocompatibility Antigens Class I/*genetics MH - Histocompatibility Antigens Class II/*genetics MH - Humans MH - Male MH - Middle Aged MH - Pemphigus/*genetics MH - Polymerase Chain Reaction MH - Turkey EDAT- 2013/01/03 06:00 MHDA- 2013/06/21 06:00 CRDT- 2013/01/03 06:00 PHST- 2013/01/03 06:00 [entrez] PHST- 2013/01/03 06:00 [pubmed] PHST- 2013/06/21 06:00 [medline] AID - 10.1111/j.1365-4632.2012.05541.x [doi] PST - ppublish SO - Int J Dermatol. 2013 Jan;52(1):53-8. doi: 10.1111/j.1365-4632.2012.05541.x.